Radnor Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-667
Closed -$56K 182
2018
Q3
$56K Hold
667
0.02% 180
2018
Q2
$64K Hold
667
0.02% 173
2018
Q1
$70K Hold
667
0.02% 176
2017
Q4
$104K Buy
+667
New +$104K 0.03% 178